Study maps negative effects of psychedelic drugs to inform safer clinical use

Researchers have identified and catalogued the challenging experiences people report after using classic psychedelics like psilocybin and LSD. The findings matter to pharmaceutical companies, regulators, and mental health providers now racing to develop psychedelic therapies—understanding these risks is essential for patient safety protocols and informed consent.

Originaltitel: Prevalence and associations of challenging, difficult or distressing experiences using classic psychedelics